Autocrine semaphorin 3A signaling promotes glioblastoma dispersal

Oncogene

Volumn 28, Issue 40, 2009, Pages 3537-3550

  Bagci, T ^a   Wu, J K ^a   Pfannl, R ^a   Ilag, L L ^b   Jay, D G ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Dispersal; Glioma; Neuropilin; Proteomics; Semaphorin

Indexed keywords

NEUROPILIN 1; RAC1 PROTEIN; SEMAPHORIN 3A;

ARTICLE; AUTOCRINE EFFECT; BRAIN; CANCER CELL; CANCER INVASION; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FUNCTIONAL PROTEOMICS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

AUTOCRINE COMMUNICATION; BRAIN CHEMISTRY; BRAIN NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; GLIOBLASTOMA; HUMANS; NEOPLASM INVASIVENESS; NEUROPILIN-1; PROTEOMICS; RAC1 GTP-BINDING PROTEIN; SEMAPHORIN-3A;

EID: 70349973901     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.204     Document Type: Article

References (57)

1. Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G et al. (2001). Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 61: 5736-5740.
2. Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ et al. (2003). Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res 63: 5230-5233.
3. Beck S, Sakurai T, Eustace BK, Beste G, Schier R, Rudert F et al. (2002). Fluorophore-assisted light inactivation: a high-throughput tool for direct target validation of proteins. Proteomics 2: 247-255.
4. Berens ME, Giese A. (1999). ?ythose left behind.? Biology and oncology of invasive glioma cells. Neoplasia 1: 208-219.
5. Broholm H, Laursen H. (2004). Vascular endothelial growth factor (VEGF) receptor neuropilin-1?s distribution in astrocytic tumors. APMIS 112: 257-263.
6. Castellani V, Chedotal A, Schachner M, Faivre-Sarrailh C, Rougon G. (2000). Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron 27: 237-249.
7. Castellani V, De Angelis E, Kenwrick S, Rougon G. (2002). Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J 21: 6348-6357.
8. Chen G, Sima J, Jin M, Wang KY, Xue XJ, Zheng W et al. (2008). Semaphorin-3A guides radial migration of cortical neurons during development. Nat Neurosci 11: 36-44.
9. Cox EA, Huttenlocher A. (1998). Regulation of integrin-mediated adhesion during cell migration. Microsc Res Tech 43: 412-419.
10. De Wit J, De Winter F, Klooster J, Verhaagen J. (2005). Semaphorin 3A displays a punctate distribution on the surface of neuronal cells and interacts with proteoglycans in the extracellular matrix. Mol Cell Neurosci 29: 40-55.
11. Del Duca D, Werbowetski T, Del Maestro RF. (2004). Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67: 295-303.
12. DiMilla PA, Stone JA, Quinn JA, Albelda SM, Lauffenburger DA. (1993). Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength. J Cell Biol 122: 729-737.
13. Ding H, Wu X, Roncari L, Lau N, Shannon P, Nagy A et al. (2000). Expression and regulation of neuropilin-1 in human astrocytomas. Int J Cancer 88: 584-592.
14. Ellis LM. (2006). The role of neuropilins in cancer. Mol Cancer Ther 5: 1099-1107.
15. Eustace BK, Sakurai T, Stewart JK, Yimlamai D, Unger C, Zehetmeier C et al. (2004). Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasive-ness. Nat Cell Biol 6: 507-514.
16. Fukahi K, Fukasawa M, Neufeld G, Itakura J, Korc M. (2004). Aberrant expression of neuropilin-1 and-2 in human pancreatic cancer cells. Clin Cancer Res 10: 581-590.
17. Guo W, Giancotti FG. (2004). Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5: 816-826.
18. Halloran MC, Wolman MA. (2006). Repulsion or adhesion: receptors make the call. Curr Opin Cell Biol 18: 533-540.
19. Hoelzinger DB, Demuth T, Berens ME. (2007). Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J Natl Cancer Inst 99: 1583-1593.
20. Holland EC. (2001). Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2: 120-129.
21. Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O et al. (2007). Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene 26: 5577-5586.
22. Kawakami T, Tokunaga T, Hatanaka H, Kijima H, Yamazaki H, Abe Y et al. (2002). Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer 95: 2196-2201.
23. Klagsbrun M, Takashima S, Mamluk R. (2002). The role of neuropilin in vascular and tumor biology. Adv Exp Med Biol 515: 33-48.
24. Kolodkin AL, Levengood DV, Rowe EG, Tai YT, Giger RJ, Ginty DD. (1997). Neuropilin is a semaphorin III receptor. Cell 90: 753-762.
25. Kreuter M, Woelke K, Bieker R, Schliemann C, Steins M, Buechner T et al. (2006). Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia 20: 1950-1954.
26. Lee P, Goishi K, Davidson AJ, Mannix R, Zon L, Klagsbrun M. (2002). Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc Natl Acad Sci USA 99: 10470-10475.
27. Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC et al. (2004). Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 101: 2341-2350. (Pubitemid 39458692)
28. Mertsch S, Schmitz N, Jeibmann A, Geng JG, Paulus W, Senner V. (2008). Slit2 involvement in glioma cell migration is mediated by Robo1 receptor. J Neurooncol 87: 1-7.
29. Miao HQ, Lee P, Lin H, Soker S, Klagsbrun M. (2000). Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J 14: 2532-2539.
30. Muller MW, Giese NA, Swiercz JM, Ceyhan GO, Esposito I, Hinz U et al. (2007). Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 121: 2421-2433.
31. Nakada M, Drake KL, Nakada S, Niska JA, Berens ME. (2006). Ephrin-B3 ligand promotes glioma invasion through activation of Rac1. Cancer Res 66: 8492-8500.
32. Nakada M, Niska JA, Miyamori H, McDonough WS, Wu J, Sato H et al. (2004). The phosphorylation of EphB2 receptor regulates migration and invasion of human glioma cells. Cancer Res 64: 3179-3185.
33. Nobes CD, Hall A. (1999). Rho GTPases control polarity, protrusion, and adhesion during cell movement. J Cell Biol 144: 1235-1244.
34. Okada H, Yoshida J, Sokabe M, Wakabayashi T, Hagiwara M. (1996). Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int J Cancer 66: 255-260.
35. Osada H, Tokunaga T, Nishi M, Hatanaka H, Abe Y, Tsugu A et al. (2004). Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res 24: 547-552.
36. Pan Q, Chanthery Y, Liang WC, Stawicki S, Mak J, Rathore N et al. (2007). Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell 11: 53-67.
37. Parikh AA, Fan F, Liu WB, Ahmad SA, Stoeltzing O, Reinmuth N et al. (2004). Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol 164: 2139-2151.
38. Polleux F, Morrow T, Ghosh A. (2000). Semaphorin 3A is a chemoattractant for cortical apical dendrites. Nature 404: 567-573.
39. Raper JA. (2000). Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 10: 88-94.
40. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G et al. (2003). Cell migration: integrating signals from front to back. Science 302: 1704-1709.
41. Rieger J, Wick W, Weller M. (2003). Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42: 379-389.
42. Roche J, Drabkin H, Brambilla E. (2002). Neuropilin and its ligands in normal lung and cancer. Adv Exp Med Biol 515: 103-114.
43. Rossignol M, Gagnon ML, Klagsbrun M. (2000). Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics 70: 211-222.
44. Roush W. (1998). Receptor links blood vessels, axons. Science 279: 2042.
45. Serini G, Valdembri D, Zanivan S, Morterra G, Burkhardt C, Caccavari F et al. (2003). Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 424: 391-397.
46. Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, Simeone M et al. (2004). CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 4: 73.
47. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735-745.
48. Song H, Ming G, He Z, Lehmann M, McKerracher L, Tessier-Lavigne M et al. (1998). Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides. Science 281: 1515-1518.
49. Staton CA, Kumar I, Reed MW, Brown NJ. (2007). Neuropilins in physiological and pathological angiogenesis. J Pathol 212: 237-248.
50. Subauste MC, Von Herrath M, Benard V, Chamberlain CE, Chuang TH, Chu K et al. (2000). Rho family proteins modulate rapid apoptosis induced by cytotoxic T lymphocytes and Fas. J Biol Chem 275: 9725-9733.
51. Tran TS, Kolodkin AL, Bharadwaj R. (2007). Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol 23: 263-292.
52. Turner LJ, Nicholls S, Hall A. (2004). The activity of the plexin-A1 receptor is regulated by Rac. J Biol Chem 279: 33199-33205.
53. Vales A, Kondo R, Aichberger KJ, Mayerhofer M, Kainz B, Sperr WR et al. (2007). Myeloid leukemias express a broad spectrum of VEGF receptors including neuropilin-1 (NRP-1) and NRP-2. Leuk Lymphoma 48: 1997-2007.
54. Vanveldhuizen PJ, Zulfiqar M, Banerjee S, Cherian R, Saxena NK, Rabe A et al. (2003). Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. Oncol Rep 10: 1067-1071.
55. Wey JS, Gray MJ, Fan F, Belcheva A, McCarty MF, Stoeltzing O et al. (2005). Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 93: 233-241.
56. Zhou Y, Gunput RA, Pasterkamp RJ. (2008). Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci 33: 161-170.
57. Ziegler WH, Liddington RC, Critchley DR. (2006). The structure and regulation of vinculin. Trends Cell Biol 16: 453-460.